Trial NCT01776008

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2013-00080
Secondary IDs: 9170 MC1139 N01CM00071 N01CM00099 NCI-2013-00080 P30CA015083

Last trial update was posted on 2018-05-08

MeSH Interventions

Anastrozole Goserelin

MeSH Conditions

Breast Neoplasms

Other Conditions

Estrogen Receptor Positive HER2/Neu Negative Recurrent Breast Carcinoma Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer

Stopping Reasons

Study did not pass Stage 1 interim analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID